News

ReachBio’s COO, Rob Chaney, talks cellPrism® and growth with CEOCFO Magazine

Rob Chaney, Co-Founder, COO & General Manager

Rob Chaney, Co-Founder, COO & General Manager

Blood and Bone Marrow Primary Cell Contract Research Services using the CellPrism® Platform to provide Predictive and Investigative Toxicology, Immuno-Oncology, and Antibody Testing for Drug Development and Life Science Companies

Interview conducted by: Lynn Fosse, Senior Editor, CEOCFO Magazine, Published – April 24, 2017

CEOCFO: Mr.

Read more →

 

Applied Pharmaceutical Toxicology 2017

We’re excited to announce we’ll be exhibiting at this year’s Applied Pharmaceutical Toxicology (APT) Conference  in San Francisco, California
at Genentech in building 35, May 15th – 17th.

Stop by our booth to learn about cellPrism®, our in vitro drug development platform, and hear how our primary cell toxicology and immunology assays can help address your drug development program challenges.…

Read more →

 

SOT 56th Annual Meeting and ToxExpo

We’re happy to announce we’ll be exhibiting at this year’s ToxExpo at the Society of Toxicology (SOT) 56th Annual Meeting in Baltimore, Maryland. Our booth, #1616, will display a range of customizable cell-based contract assay services for life science and pharmaceutical organizations worldwide.…

Read more →

 

ReachBio Research Labs Launches a New Drug Development Platform, cellPrism®

SEATTLE, Jan. 31, 2017 /PRNewswire/ — ReachBio Research Labs (trade name under Reachbio LLC®) has announced the launch of their new drug development platform, cellPrism®. The platform is designed to offer biotechnology and pharmaceutical companies a spectrum of customized in vitro assays to assess and evaluate potential program challenges that may arise during the drug development process.…

Read more →

 

Happy New Year from ReachBio Research Labs!

It’s been a good year for growth at ReachBio Research Labs! We’ve really enjoyed working with our existing clients, new clients and those who’ve come back with new contract service and/or product interests. We always strive to facilitate each of our clients’ needs.…

Read more →